-
264%
NPM-1 Mutation Detection By PC ...
Hotspot genes: ABL1, BRAF, CBL, CSF3R, DNMT3A, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL,…NPM-1 Mutation Detection By PC ...
Hotspot genes: ABL1, BRAF, CBL, CSF3R, DNMT3A, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL,… -
272%
NTRK PANEL BY NGS
Identification of therapeutically relevant gene mutations for Cancer - 264%
-
272%
ONCQUER ASSIST PANEL
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUER CTC MONITORING (2 TEST ...
Identification of therapeutically relevant gene mutations for CancerONCQUER CTC MONITORING (2 TEST ...
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUER CTC MONITORING (3 TEST ...
Identification of therapeutically relevant gene mutations for CancerONCQUER CTC MONITORING (3 TEST ...
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUER CTC TESTING (1 TEST)
Identification of therapeutically relevant gene mutations for Cancer -
272%
Oncquer Germline Mutation Spec ...
Identification of therapeutically relevant gene mutations for CancerOncquer Germline Mutation Spec ...
Identification of therapeutically relevant gene mutations for Cancer -
264%
OncQuer TM Scout LB 56 Gene T ...
Identification of therapeutically relevant gene mutations for Myeloid cancerCancerOncQuer TM Scout LB 56 Gene T ...
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer